Related Experiment Video
Updated: Jul 11, 2026
09:25
Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Drug interactions with smoking.
1Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, 3333 California Street, Suite 420, Box 0613, San Francisco, CA 94118, USA. kroonl@pharmacy.ucsf.edu
Summary
Smoking significantly impacts drug efficacy and metabolism through interactions with cytochrome P-450 enzymes. Smokers may need higher drug doses, while cessation requires dosage adjustments to prevent adverse effects.
Area of Science:
- Pharmacology
- Toxicology
- Drug Metabolism
Background:
- Tobacco smoke contains polycyclic aromatic hydrocarbons (PAHs), potent inducers of hepatic cytochrome P-450 (CYP) isoenzymes, particularly CYP1A2.
- Understanding these interactions is crucial for managing patient care, especially during smoking cessation.
Purpose of the Study:
- To review the mechanisms of drug interactions associated with smoking.
- To identify clinically significant pharmacokinetic and pharmacodynamic drug interactions related to smoking.
Main Methods:
- Literature review of drug interactions with smoking.
- Analysis of pharmacokinetic and pharmacodynamic alterations caused by tobacco smoke components.
Main Results:
- PAHs in smoke induce CYP1A1, CYP1A2, and CYP2E1, affecting the metabolism of numerous drugs.
- Key pharmacokinetic interactions involve CYP1A2 substrates (e.g., caffeine, clozapine, theophylline) and inhaled insulin.
- Significant pharmacodynamic interactions include reduced efficacy of hormonal contraceptives and inhaled corticosteroids in smokers.
Conclusions:
- Smokers may require higher medication dosages due to induced drug metabolism.
- Smoking cessation necessitates careful dosage reduction of interacting medications to avoid toxicity.
- Contraindications exist for combined hormonal contraceptives in women over 35 who smoke due to cardiovascular risks.
Related Concept Videos
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:30Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...